Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation
Authors:
- 30 July 2009
- journal article
- Published by Wiley in Hepatology Research
- Vol. 39 (8) , 772-778
Abstract
Aim: Partial splenic embolization (PSE) is a non‐surgical procedure developed to treat hypersplenism. The purpose of this study is to evaluate therapeutic benefits of PSE with follow‐up radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC) patients with thrombocytopenia.Methods: Between September 1999 and January 2007, a total of 20 patients with HCC who had a few lesions, each 3 cm or less in diameter, and liver function of Child‐Pugh class A or B were enrolled into our study. The patients were diagnosed with marked thrombocytopenia (3/mm3), or mild thrombocytopenia (3/mm3) with decreased prothrombin activity. They were treated once or twice with PSE. RFA was given as a follow‐up treatment 2 weeks after final PSE. The primary endpoint was a platelet‐count increase and improvement of prothrombin activity, and the secondary endpoint was the initiation of RFA.Results: PSE was performed successfully in 19 patients (95%). Two weeks after final PSE, platelet counts increased significantly (38 ± 14 × 103/mm3 vs. 97 ± 43 × 103/mm3; P < 0.0001), and prothrombin activity improved significantly (59.3 ± 19.8% vs. 65.2 ± 17.9%; P < 0.0001). No patients had major complications during the PSE procedure. The secondary endpoint was achieved in 18 of 19 patients (94.7%). The mean overall survival was 2257 days (95% confidence interval; range, 1659−2855 days). The Kaplan‐Meier cumulative survival rate was estimated to be 61.9% at 5 years.Conclusions: PSE is a safe and effective treatment for thrombocytopenia and has adjuvant therapeutic benefits for the therapy of HCC.Keywords
This publication has 30 references indexed in Scilit:
- Recent role of splenectomy in chronic hepatic disordersHepatology Research, 2008
- Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?Hepatology, 2007
- Partial splenic embolizationHepatology Research, 2007
- Protracted pain following partial splenic embolization in an adolescent female with hypersplenismPediatric Anesthesia, 2005
- Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral centerLiver Transplantation, 2004
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Partial splenic embolization in children with hypersplenismThe Journal of Pediatrics, 1994
- Splenic embolization in children: Long-term efficacyJournal of Pediatric Surgery, 1989
- Embolic Therapy of HypersplenismInvestigative Radiology, 1973
- The Relationship between Splenic Platelet Pool and Spleen SizeScandinavian Journal of Haematology, 1972